InvestorsHub Logo
icon url

BigBadWolf

04/27/23 3:50 PM

#58017 RE: BigBadWolf #58015

How times change how long Dixon knew NoOngoingPhase3
September 20, 2022 09:00 AM Eastern Daylight Time
https://www.businesswire.com/news/home/20220920005776/en/Therapeutic-Solutions-International-Secures-Financing-to-Complete-Current-Phase-III-Stem-Cell-Clinical-Trial

This financing will allow the acceleration of our current Phase III clinical trial assessing efficacy of JadiCells, a novel adult stem cell, for treatment of COVID-19 associated lung injury,” said Timothy Dixon, President, and CEO of Therapeutic Solutions International. “The implications of this trial are far-reaching in that success will open the door for entry into other pulmonary indications including ‘long COVID’ which remains a significant health problem.”


USE OF PROCEEDS
We will not receive any proceeds from the sale of the common stock by the selling stockholders.

The Company will retain broad discretion over the use of the net proceeds from the sale of the securities to purchaser. We currently intend to use the net proceeds for working capital, capital expenditures, extinguishment of debt or other liabilities, and general corporate purposes. We may also use a portion of the net proceeds to invest in or acquire businesses or technologies that we believe are complementary to our own, although we have no current commitments or binding agreements with respect to any acquisitions as of the date of this prospectus.


How long??? perhaps start @ least here

Back in April 2022

https://forum.therapeuticsolutionsint.com/viewtopic.php?p=16064&hilit=check#p16064
&
another referral ;-)
icon url

BigBadWolf

04/28/23 4:03 PM

#58060 RE: BigBadWolf #58015

another 1,500,000 @002955 avg 15:44:15